The 15th International Epilepsy Colloquium: Ictal Semiology and its Value in Epilepsy Surgery

The Colloquium brings together the most recognized experts in the field of epilepsy. The 2023 Colloquium will focus on the semiology of epileptic seizures and its value in epilepsy surgery. Numerous case discussions strive to make the sessions interactive to facilitate active audience participation in the interchange of ideas. The Colloquium is designed for epileptologists, neurosurgeons, and neurologists. Nurses, neuropsychologists, EEG technologists and other health care professionals are also welcome to attend.

Scientific Committee

Alexis Arzimanoglou Philippe Kahane
Andrew Bleasel Susanne Knake
Helen Cross Hans O Lüders
John Duncan Jonathan Miller
Guadalupe Fernandez-Baca Vaca         Felix Rosenow
Edoardo Hirsch  Philippe Ryvlin

Registration to open March 2023

Monday, September 18, 2023, 7:00 AM - Friday, September 22, 2023, 6:30 PM, Tinkham Veale University Center, Cleveland, OH

1. Recognize how seizure semiology can be deftly used to localize seizure onset
2. Identify ictal propagation pathways through analysis of the sequence of development of different semiologic features
3. Define the traps and pitfalls in applying seizure semiology for localization of the epileptogenic zone

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this live activity for a maximum of 35.0 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation of Relevant Financial Relationships

 CWRU School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.